{
  "genomic_analysis": {
    "sample_info": {
      "sample_id": "GEN-2025-001",
      "sample_type": "Tumor tissue",
      "collection_date": "2025-01-18",
      "sequencing_platform": "Illumina NovaSeq 6000",
      "panel_type": "Comprehensive Cancer Panel",
      "coverage_depth": "500x",
      "quality_metrics": {
        "q30_percentage": 94.2,
        "total_reads": 45000000,
        "uniformity": 0.89
      }
    },
    "mutations": [
      {
        "gene": "KRAS",
        "variant": "p.G12D",
        "chromosome": "12",
        "position": 25245350,
        "ref_allele": "C",
        "alt_allele": "A",
        "variant_type": "Missense",
        "allele_frequency": 0.42,
        "read_depth": 523,
        "clinical_significance": "Pathogenic",
        "oncogene_status": "Driver mutation",
        "therapeutic_implications": [
          "Resistance to EGFR inhibitors",
          "Potential MEK inhibitor sensitivity"
        ]
      },
      {
        "gene": "TP53",
        "variant": "p.R273H",
        "chromosome": "17",
        "position": 7673803,
        "ref_allele": "G",
        "alt_allele": "A",
        "variant_type": "Missense",
        "allele_frequency": 0.38,
        "read_depth": 445,
        "clinical_significance": "Pathogenic",
        "oncogene_status": "Tumor suppressor loss",
        "therapeutic_implications": [
          "Poor prognosis marker",
          "Chemotherapy resistance"
        ]
      },
      {
        "gene": "CDKN2A",
        "variant": "p.R58*",
        "chromosome": "9",
        "position": 21971207,
        "ref_allele": "C",
        "alt_allele": "T",
        "variant_type": "Nonsense",
        "allele_frequency": 0.45,
        "read_depth": 398,
        "clinical_significance": "Pathogenic",
        "oncogene_status": "Tumor suppressor loss",
        "therapeutic_implications": [
          "CDK4/6 inhibitor potential",
          "Cell cycle dysregulation"
        ]
      },
      {
        "gene": "SMAD4",
        "variant": "p.Q249*",
        "chromosome": "18",
        "position": 51028631,
        "ref_allele": "C",
        "alt_allele": "T",
        "variant_type": "Nonsense",
        "allele_frequency": 0.41,
        "read_depth": 412,
        "clinical_significance": "Pathogenic",
        "oncogene_status": "Tumor suppressor loss",
        "therapeutic_implications": [
          "TGF-Î² pathway disruption",
          "Poor prognosis"
        ]
      }
    ],
    "copy_number_variants": [
      {
        "gene": "MYC",
        "chromosome": "8",
        "copy_number": 4.2,
        "status": "Amplified",
        "significance": "Oncogene amplification"
      },
      {
        "gene": "CDKN2A",
        "chromosome": "9",
        "copy_number": 0.3,
        "status": "Deleted",
        "significance": "Tumor suppressor loss"
      }
    ],
    "microsatellite_instability": {
      "status": "MSS",
      "msi_score": 0.12,
      "markers_tested": ["BAT25", "BAT26", "D2S123", "D5S346", "D17S250"],
      "interpretation": "Microsatellite stable"
    },
    "tumor_mutational_burden": {
      "value": 3.2,
      "unit": "mutations/Mb",
      "classification": "Low",
      "percentile": 25
    },
    "homologous_recombination_deficiency": {
      "hrd_score": 15,
      "status": "HRD-negative",
      "loh_score": 8,
      "tai_score": 4,
      "lst_score": 3
    },
    "therapeutic_targets": [
      {
        "gene": "KRAS G12D",
        "drug": "Sotorasib",
        "evidence_level": "FDA Approved",
        "indication": "KRAS G12C (not applicable)",
        "notes": "G12D variant - investigational agents available"
      },
      {
        "pathway": "MEK pathway",
        "drug": "Trametinib",
        "evidence_level": "Clinical Trial",
        "indication": "KRAS-mutant pancreatic cancer",
        "notes": "Combination therapy recommended"
      }
    ],
    "biomarkers": {
      "pd_l1_expression": {
        "percentage": 5,
        "classification": "Low",
        "antibody": "22C3"
      },
      "her2_status": {
        "ihc_score": "1+",
        "fish_ratio": null,
        "status": "Negative"
      }
    }
  },
  "pharmacogenomics": [
    {
      "gene": "CYP2D6",
      "genotype": "*1/*4",
      "phenotype": "Intermediate metabolizer",
      "drugs_affected": ["Codeine", "Tamoxifen", "Metoprolol"],
      "recommendations": "Dose adjustment may be required"
    },
    {
      "gene": "TPMT",
      "genotype": "*1/*1",
      "phenotype": "Normal metabolizer",
      "drugs_affected": ["6-mercaptopurine", "Azathioprine"],
      "recommendations": "Standard dosing appropriate"
    },
    {
      "gene": "UGT1A1",
      "genotype": "*28/*28",
      "phenotype": "Poor metabolizer",
      "drugs_affected": ["Irinotecan"],
      "recommendations": "Reduced starting dose recommended"
    }
  ]
}
